Progyny Inc
NASDAQ:PGNY
Progyny Inc
NASDAQ:PGNY
Price:
17.93
USD
1.76%
Market Closed
Market Cap:
$1.5B
Relative Value
The Relative Value of one
PGNY
stock under the Base Case scenario is
27.22
USD.
Compared to the current market price of 17.93 USD,
Progyny Inc
is
Undervalued by 34%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PGNY
Relative Value
Base Case
27.22
USD
Undervaluation 34%
Multiples Across Competitors
PGNY Competitors Multiples
Progyny Inc Competitors
Progyny Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Progyny Inc
NASDAQ:PGNY
|
1.5B USD | 1.1 | 25.1 | 12.1 | 12.7 | |
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
260.2B USD | 0.6 | 21.6 | 0 | 0 | |
| US |
A
|
Anthem Inc
LSE:0HG8
|
73.3B USD | 0.4 | 13 | 0 | 0 | |
| US |
|
Elevance Health Inc
NYSE:ELV
|
63.8B USD | 0.3 | 11.3 | 0 | 0 | |
| US |
|
Humana Inc
NYSE:HUM
|
21.6B USD | 0.2 | 18.2 | 0 | 0 | |
| US |
|
Centene Corp
NYSE:CNC
|
21.5B USD | 0.1 | -3.2 | 0 | 0 | |
| US |
|
Molina Healthcare Inc
NYSE:MOH
|
7.5B USD | 0.2 | 15.8 | 3.2 | 4 | |
| US |
|
Healthequity Inc
NASDAQ:HQY
|
6.8B USD | 5.1 | 34.5 | 16 | 24.4 | |
| US |
M
|
Magellan Health Inc
F:MAH1
|
2.2B EUR | 0.5 | 8.5 | 12.9 | 38.5 | |
| BR |
|
Odontoprev SA
BOVESPA:ODPV3
|
7.4B BRL | 3.1 | 12.8 | 8.6 | 9.3 | |
| US |
|
Clover Health Investments Corp
NASDAQ:CLOV
|
1B USD | 0.6 | -17.4 | -14.5 | -14.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
